Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$282K Buy
3,648
+147
+4% +$11.7K 0.66% 51
2021
Q3
$265K Sell
3,501
-50,993
-94% -$3.88M 0.43% 63
2021
Q2
$4.27M Sell
54,494
-3,645
-6% -$271K 2.35% 7
2021
Q1
$4.31M Buy
58,139
+283
+0.5% +$20.9K 2.47% 6
2020
Q4
$4.55M Buy
57,856
+3,943
+7% +$302K 2.48% 7
2020
Q3
$4.3M Sell
53,913
-207
-0.4% -$16.2K 2.29% 7
2020
Q2
$4.02M Sell
54,120
-4,168
-7% -$314K 2.27% 6
2020
Q1
$4.31M Sell
58,288
-38,049
-39% -$2.99M 2.54% 4
2019
Q4
$7.58M Buy
96,337
+80,795
+520% +$6.64M 3.84% 2
2019
Q3
$1.25M Buy
15,542
+880
+6% +$70.5K 1.1% 21
2019
Q2
$1.14M Buy
14,662
+753
+5% +$57.7K 1.21% 19
2019
Q1
$1.11M Sell
13,909
-3,701
-21% -$277K 1.45% 17
2018
Q4
$1.28M Buy
+17,610
New +$1.24M 0.66% 40

Other funds holding MRK

Hayden Royal's MRK Position: Q4 2021 in Review

Hayden Royal increased its Merck (MRK) stake by 4.2% in Q4 2021, buying an estimated $11.7K and bringing the position to 3,648 shares worth $282K. The position accounts for 0.66% of the portfolio, ranked #51.

Hayden Royal first reported a position in MRK in Q4 2018 and has held it in 13 quarters since. The position peaked at $7.58M in Q4 2019. 2,902 funds tracked by Wall St. Rank hold MRK as of Q4 2021.

  • Hayden Royal held 3,648 shares of Merck worth $282K as of Q4 2021.
  • Hayden Royal bought 147 Merck shares in Q4 2021, an estimated $11.7K.
  • Merck made up 0.66% of Hayden Royal's portfolio in Q4 2021, its #51 holding.
  • Hayden Royal first reported a position in Merck in Q4 2018 and has held it in 13 quarters since.
  • Hayden Royal's Merck position peaked at $7.58M in Q4 2019.
  • 2,902 funds tracked by Wall St. Rank held Merck as of Q4 2021.

Based on Hayden Royal's 13F filing for Q4 2021, filed 7 Feb 2022.